These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 32278042)
1. Natural and synthetic compounds as dissociated agonists of glucocorticoid receptor. Zhang T; Liang Y; Zhang J Pharmacol Res; 2020 Jun; 156():104802. PubMed ID: 32278042 [TBL] [Abstract][Full Text] [Related]
2. Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds. Sundahl N; Bridelance J; Libert C; De Bosscher K; Beck IM Pharmacol Ther; 2015 Aug; 152():28-41. PubMed ID: 25958032 [TBL] [Abstract][Full Text] [Related]
3. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204 [TBL] [Abstract][Full Text] [Related]
4. Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system? De Bosscher K; Beck IM; Haegeman G Brain Behav Immun; 2010 Oct; 24(7):1035-42. PubMed ID: 20600811 [TBL] [Abstract][Full Text] [Related]
5. Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore. Razavi H; Riether D; Harcken C; Bentzien J; Dinallo RM; Souza D; Nelson RM; Kukulka A; Fadra-Khan TN; Pack EJ; Zuvela-Jelaska L; Pelletier J; Panzenbeck M; Torcellini CA; Proudfoot JR; Nabozny GH; Thomson DS Bioorg Med Chem Lett; 2014 Apr; 24(8):1934-40. PubMed ID: 24656565 [TBL] [Abstract][Full Text] [Related]
6. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation. Vandevyver S; Dejager L; Tuckermann J; Libert C Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835 [TBL] [Abstract][Full Text] [Related]
7. Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects. McMaster A; Ray DW Exp Physiol; 2007 Mar; 92(2):299-309. PubMed ID: 17138619 [TBL] [Abstract][Full Text] [Related]
8. Discovery of quinolines as selective glucocorticoid receptor agonists. Jaroch S; Berger M; Huwe C; Krolikiewicz K; Rehwinkel H; Schäcke H; Schmees N; Skuballa W Bioorg Med Chem Lett; 2010 Oct; 20(19):5835-8. PubMed ID: 20727743 [TBL] [Abstract][Full Text] [Related]
9. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor? Newton R; Holden NS Mol Pharmacol; 2007 Oct; 72(4):799-809. PubMed ID: 17622575 [TBL] [Abstract][Full Text] [Related]
11. A high-throughput chemical screen identifies novel inhibitors and enhancers of anti-inflammatory functions of the glucocorticoid receptor. Jiang X; Dahlin A; Weiss ST; Tantisira K; Lu Q Sci Rep; 2017 Aug; 7(1):7405. PubMed ID: 28785063 [TBL] [Abstract][Full Text] [Related]
12. Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor. Clark AR; Belvisi MG Pharmacol Ther; 2012 Apr; 134(1):54-67. PubMed ID: 22212616 [TBL] [Abstract][Full Text] [Related]
13. Discovery of Compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activity. Lesovaya E; Yemelyanov A; Swart AC; Swart P; Haegeman G; Budunova I Oncotarget; 2015 Oct; 6(31):30730-44. PubMed ID: 26436695 [TBL] [Abstract][Full Text] [Related]
14. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Vayssière BM; Dupont S; Choquart A; Petit F; Garcia T; Marchandeau C; Gronemeyer H; Resche-Rigon M Mol Endocrinol; 1997 Aug; 11(9):1245-55. PubMed ID: 9259316 [TBL] [Abstract][Full Text] [Related]
15. Beneficial pharmacological effects of selective glucocorticoid receptor agonist in external eye diseases. Kato M; Hagiwara Y; Oda T; Imamura-Takai M; Aono H; Nakamura M J Ocul Pharmacol Ther; 2011 Aug; 27(4):353-60. PubMed ID: 21574866 [TBL] [Abstract][Full Text] [Related]
16. Novel glucocorticoid receptor agonists in the treatment of asthma. Cazzola M; Coppola A; Rogliani P; Matera MG Expert Opin Investig Drugs; 2015; 24(11):1473-82. PubMed ID: 26293110 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and local anti-inflammatory activity of 17β-carboxamide derivatives of glucocorticoids. Dobričić V; Marković B; Milenković N; Savić V; Jaćević V; Rančić N; Vladimirov S; Cudina O Arch Pharm (Weinheim); 2014 Nov; 347(11):786-97. PubMed ID: 25159891 [TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effects of selective glucocorticoid receptor modulators are partially dependent on up-regulation of dual specificity phosphatase 1. Joanny E; Ding Q; Gong L; Kong P; Saklatvala J; Clark AR Br J Pharmacol; 2012 Feb; 165(4b):1124-36. PubMed ID: 21718312 [TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rg1 Acts as a Selective Glucocorticoid Receptor Agonist with Anti-Inflammatory Action without Affecting Tissue Regeneration in Zebrafish Larvae. He M; Halima M; Xie Y; Schaaf MJM; Meijer AH; Wang M Cells; 2020 Apr; 9(5):. PubMed ID: 32365641 [TBL] [Abstract][Full Text] [Related]
20. An analysis of glucocorticoid receptor-mediated gene expression in BEAS-2B human airway epithelial cells identifies distinct, ligand-directed, transcription profiles with implications for asthma therapeutics. Joshi T; Johnson M; Newton R; Giembycz M Br J Pharmacol; 2015 Mar; 172(5):1360-78. PubMed ID: 25393397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]